# Embold Therapeutics, Inc. — Form D

Embold Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-09. The offering totals $3.0M, of which $130K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-02-09
- Form: D
- Accession: 0002109643-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $130K
- Remaining: $2.9M
- Investors: 2
- Date of first sale: 2026-01-21
- Revenue range: Decline to Disclose
- SEC file number: 021-572899

## Issuer

- Name: Embold Therapeutics, Inc.
- CIK: 0002109643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2682 EATON AVE, REDWOOD CITY, CA, 94062
- Phone: (650) 200-7297

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Gjalt W. Huisman | Director | Redwood City, CA |
| Gjalt W. Huisman | Executive Officer | Redwood City, CA |
| Gjalt W. Huisman | Related Person | Redwood City, CA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-07-24](https://search.stillhousedata.com/formd/0002109643-26-000003) | D/A | $5.0M | $2.5M |
| [2026-02-09](https://search.stillhousedata.com/formd/0002109643-26-000001) | D | $500K | $500K |

## More

- [CIK 2109643 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2109643&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002109643-26-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.